Showing results (1-10 of 189) with videos related to
Sort By:
Pageof 19
European Journal of Immunology|May 1, 1996
T cell major histocompatibility complex class II molecules down-regulate CD4+ T cell clone responses following LAG-3 bindingB Huard, P Prigent, F Pagès, et al.European Journal of Immunology|September 1, 1995
CD4/major histocompatibility complex class II interaction analyzed with CD4- and lymphocyte activation gene-3 (LAG-3)-Ig fusion proteinsB Huard, P Prigent, M Tournier, et al.Proceedings of the National Academy of Sciences of the United States of America|May 27, 1997
Characterization of the major histocompatibility complex class II binding site on LAG-3 proteinB Huard, R Mastrangeli, P Prigent, et al.Immunogenetics|June 20, 1998
Regulation of expression of the human lymphocyte activation gene-3 (LAG-3) molecule, a ligand for MHC class IID Bruniquel, N Borie, S Hannier, et al.Immunology Letters|July 10, 1998
LAG-3 does not define a specific mode of natural killing in humanB Huard, M Tournier, F TriebelEuropean Journal of Immunology|June 1, 2001
KIR down-regulation on NK cells is associated with down-regulation of activating receptors and NK cell inactivationB Huard, L Karlsson, F TriebelEuropean Journal of Immunology|December 22, 1999
Lymphocyte activation gene-3 induces tumor regression and antitumor immune responsesP Prigent, S El Mir, M Dréano, et al.European Journal of Immunology|December 1, 1994
Lymphocyte-activation gene 3/major histocompatibility complex class II interaction modulates the antigenic response of CD4+ T lymphocytesB Huard, M Tournier, T Hercend, et al.The Journal of Experimental Medicine|August 1, 1992
Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigensE Baixeras, B Huard, C Miossec, et al.Pageof 19